摘要
目的探讨选择性激光小梁成形术(SLT)治疗早期慢性原发性闭角型青光眼的疗效。方法59眼早期慢性原发性闭角型青光眼行激光周边虹膜成形术和激光周边虹膜切除术后,眼压>21 mmHg者再行SLT;SLT治疗后1 h、1 d、1周及1、3和6个月复查,观察不良反应、眼压以及使用降眼压药物的情况。结果SLT术后1周及1、3、6个月眼压与治疗前比较有明显下降(P<0.01)。SLT术后1个月和6个月不用药物而眼压≤21 mmHg的分别有30眼和28眼,加用1种降眼压药物者眼压≤21 mmHg的分别有11眼和15眼,加用2种局部降眼压药物者眼压≤21 mmHg的分别有10眼和9眼,加用2种局部降眼压药物者眼压>21 mmHg的分别有8眼和7眼。结论早期慢性原发性闭角型青光眼激光周边虹膜切除术和激光周边虹膜成形术后,SLT是安全有效的降眼压方法。
Objective To evaluate the therapeutic effect of selective laser trabecularplasty（SLT） on early chronic primary angle-closure glaucoma （CPACG）. Methods Fifty-nine eyes of early CPACG without fundus and visual field change were treated by laser peripheral iridoplasty and laser iridectomy. SLT was performed on those with intraocular pressure（IOP） 〉 21 mmHg. The side effects, IOP and application of anti-glaucoma drugs were examined 1 h, 1 d, 1 week, 1 month, 3 months and 6 months after SLT. Results The IOP was significantly decreased 1 week, 1 month, 3 months and 6 months after SLT compared with that before treatment （P 〈 0.01 ）. One month and 6 months after treatment, there were 30 eyes and 28 eyes with IOP≤21 mmHg without using anti-glaucoma drug, 11 eyes and 15 eyes with IOP≤21 mmHg using one anti-glaucoma drug, 10 eyes and 9 eyes with IOP≤21 mmHg using two anti-glaucoma drugs, and 8 eyes and 7 eyes with IOP 〉21 mmHg using two anti-glaucoma drugs, respectively. Conclusion SLT is a safe and effective method for IOP control in early CPACG after treatment with laser peripheral iridoplasty and laser iridectomy.
出处
《上海交通大学学报（医学版）》
CAS
CSCD
北大核心
2008年第6期710-712,共3页
Journal of Shanghai Jiao tong University:Medical Science
